Unified Patent Court (UPC) analytics are now available. Check here

EP3434265

SANDOZ
Application Number
EP18193241A
Filing Date
Mar 22, 2017
Status
Revoked
May 24, 2024
Grant Date
Jul 7, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3434265B1 was granted on Jul 7, 2021 by Sandoz The patent is currently Revoked.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICAL INDUSTRIESApr 7, 2022ADMISSIBLE
ALFRED E TIEFENBACHERApr 6, 2022ADMISSIBLE
ALFASIGMAMar 21, 2022ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionEP3294270B1
N/A
OppositionEP3373914B2
N/A
OppositionWO2005044823
N/A
OppositionEP1557421
N/A
OppositionEP1698630
N/A
OppositionEP2927235
N/A
OppositionWO2011107970
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents